US Patent Issued to ADARx Pharmaceuticals on April 7 for "Complement Factor B-modulating compositions and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,477, issued on April 7, was assigned to ADARx Pharmaceuticals Inc. (San Diego).

"Complement Factor B-modulating compositions and methods of use thereof" was invented by Zhen Li (San Diego), Rui Zhu (San Diego), Zhiqing (Joel) Zhou (San Diego), Sean Studer (San Diego), Kimberly Fultz (San Diego) and Jean da Silva Correia (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure provide compounds, compositions, and methods for modulating the expression or activity of Complement Factor B (CFB). In certain aspects, the compounds, compositions, and methods of the disclosure can be used to reduce the expression of CFB mRNA in a c...